Zhao Zhifeng, Wang Kai, Tan Shanfeng
Department of Urology, Linyi People's Hospital of Shandong Province, 276000, Linyi, P. R. China.
Cancer Gene Ther. 2021 May;28(5):514-528. doi: 10.1038/s41417-020-00237-w. Epub 2020 Nov 22.
Prostate cancer (PCa) stem cells increase the sustainability of tumor growth, resulting in high relapse rates in patients with PCa. This goal of the present study was to elucidate the function of microRNA (miR)-211 in PCa stem cell activities. Based on the initial findings from the GSE26910 dataset, inhibin-β A (INHBA) was used for subsequent experiments, and miR-211 was then predicted as a candidate regulatory miR. Subsequently, INHBA and miR-211 were observed to be highly and poorly expressed in PCa tissues, respectively, and miR-211 negatively target INHBA. CD44CD133 cells were isolated, and both miR-211 and INHBA expression was altered in these cells to assess functional role of miR-211 and INHBA in PCa stem cells. Overexpression of miR-211 decreased expression of TGF-β1, TGF-β2, smad2, smad3, phosphorylated smad2 and smad3, and stem cell markers. miR-211 upregulation or INHBA knockdown resulted in reductions in the proliferation, invasion, colony-forming ability, sphere-forming ability, and stemness of PCa stem cells but enhanced their apoptosis in vitro. Furthermore, miR-211 upregulation or INHBA silencing decreased tumor growth and cell apoptosis in vivo. Taken together, these results indicate that upregulation of miR-211 has tumor-suppressive properties by inhibiting TGF-β pathway activation via INHBA in PCa stem cells.
前列腺癌(PCa)干细胞会增加肿瘤生长的可持续性,导致PCa患者的复发率很高。本研究的目的是阐明微小RNA(miR)-211在PCa干细胞活性中的作用。基于GSE26910数据集的初步发现,将抑制素-βA(INHBA)用于后续实验,然后预测miR-211为候选调控性miR。随后,观察到INHBA和miR-211分别在PCa组织中高表达和低表达,并且miR-211负向靶向INHBA。分离出CD44CD133细胞,并改变这些细胞中miR-211和INHBA的表达,以评估miR-211和INHBA在PCa干细胞中的功能作用。miR-211的过表达降低了TGF-β1、TGF-β2、smad2、smad3、磷酸化smad2和smad3以及干细胞标志物的表达。miR-211上调或INHBA敲低导致PCa干细胞的增殖、侵袭、集落形成能力、成球能力和干性降低,但增强了它们在体外的凋亡。此外,miR-211上调或INHBA沉默在体内降低了肿瘤生长和细胞凋亡。综上所述,这些结果表明,miR-211的上调通过抑制PCa干细胞中INHBA介导的TGF-β途径激活而具有肿瘤抑制特性。